Pathology in the Era of Personalized Medicine - Pharmaceutical Executive


Pathology in the Era of Personalized Medicine

Pharmaceutical Executive

Pathology, personalized medicine, and health reform

The new era of personalized medicine can also be attributed to the changing landscape of new payment models. One of many changes to how physicians are paid, due in large part to the Patient Protection and Accountable Care Act (ACA), is value-based purchasing. The primary goal of the many reforms initiated through the ACA is a reduction in cost and an improvement in quality.

As pathologists become more involved in the development, management, and application of patient information and health records, they are well-positioned to deliver care that is personally tailored, highly effective, and cost efficient.

"Pathologists are focused on patient safety and quality," said Siegal. "[Pathologists] bring to the multidisciplinary team of physicians a unique skill set for the better and encourage more interaction between pathologist and physician."

Highlighting the value of the pathologist to patient care requires pathologists to be more visible in their hospitals, but it also requires appropriate compensation, according to Siegal.

The economics of healthcare doesn't just apply solely to the cost of care to patients. Changes to reimbursements and laboratory fee schedules are also affecting pathologists. Molecular tests can be labor-intensive and costly. Third-party payer reimbursements do not reflect the cost of performing these procedures and Medicare reimbursement rates are even lower. While pathologists are up to and able to meet the challenges presented in this new era of healthcare, it is uncertain that the United States will be able to maintain an adequate supply of experts in the field without proper compensation.

Recognition as a vital member of the healthcare team

As the field of pathology has expanded, so have the skill sets, knowledge, and value of its practitioners. The field of informatics, which is growing increasingly important as a diagnostic technique, is becoming an essential area of pathology training. This new knowledge allows pathologists to gather and interpret complex patient data using 21st century technologies. Progress in the field of molecular pathology is poised to move pathology from a referral-driven specialty to one that has direct interactions with patients. Highly specialized training in the area of molecular genetics makes pathologists invaluable as we transition to the new era of personalized medicine and care. It is important to acknowledge the benefits pathologists bring to the entire healthcare team as personalized medicine promises to transform the way healthcare is provided.

Editor's note: Founded in 1922 in Chicago, the American Society for Clinical Pathology is a medical professional society with more than 100,000 member board-certified anatomic and clinical pathologists, pathology residents and fellows, laboratory professionals, and students. ASCP provides excellence in education, certification, and advocacy on behalf of patients, pathologists, and laboratory professionals. For more information, visit

Jordan Sarver is Web Writer at the American Society for Clinical Pathology. He can be reached at


blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here